praziquantel has been researched along with Non-communicable Chronic Diseases in 1 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| "Many actors responded to the London Declaration which reinforced praziquantel's central role in control and elimination of schistosomiasis whereas access to affordable insulin emerged secondary to framing around prevention and management of diabetes." | 5.05 | Spotlight on experiences of medicine unavailability: access to medicines challenges for NCDs and NTDs - the contrasting cases of insulin and praziquantel. ( Beran, D; Chappuis, F; Wells, N, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wells, N | 1 |
| Chappuis, F | 1 |
| Beran, D | 1 |
1 review available for praziquantel and Non-communicable Chronic Diseases
| Article | Year |
|---|---|
Spotlight on experiences of medicine unavailability: access to medicines challenges for NCDs and NTDs - the contrasting cases of insulin and praziquantel.
Topics: Anthelmintics; Diabetes Mellitus; Global Health; Health Services Accessibility; Humans; Hypoglycemic | 2020 |